Sign up for a free trial now

Login
Subscribe
Take a FREE Trial

About Us
Contact us
RSS

23 May 2013

Search

The Pharma Letter

Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe

CureDM Articles

Sanofi-Aventis buys global rights to CureDM’s Pancreate for up to $355 million

8 April 2010

Showing 1-1 of 1 articles

Go to beginning

Previous

1

Next

Go to end

Hot Topics
Most Read

Boehringer Ingelheim gets FDA warning letter on cGMP failures
AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
Is failure to adopt business process management putting the pharma industry at risk?
Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
Pfizer to split-off remaining 80% interest in Zoetis

Boehringer Ingelheim gets FDA warning letter on cGMP failures
AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
Is failure to adopt business process management putting the pharma industry at risk?
Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
Pfizer to split-off remaining 80% interest in Zoetis

© 2013 thepharmaletter.com

Home
RSS
About Us
Subscribe
Terms and Conditions
Article Archive

Site powered by WORKSsitebuilder CMS